GHRP-6 vs Ipamorelin
Research Verdict
Ipamorelin is the stronger research reference for the stated comparison criteria. Ipamorelin: Phase 2 post-operative ileus trial (Helsinn), demonstrated hormonal selectivity.
Quick Answers
Which is better, GHRP-6 or Ipamorelin?
Ipamorelin is the stronger research reference for the stated comparison criteria. Ipamorelin: Phase 2 post-operative ileus trial (Helsinn), demonstrated hormonal selectivity.
What is the key difference between GHRP-6 and Ipamorelin?
GHRP-6 significantly stimulates appetite and releases cortisol and prolactin alongside GH; ipamorelin releases GH without these off-target effects - ipamorelin is the cleaner secretagogue while GHRP-6 has broader hormonal impact.
Evidence Comparison
Ipamorelin: Phase 2 post-operative ileus trial (Helsinn), demonstrated hormonal selectivity. GHRP-6: more extensive pharmacological characterization but no formal clinical trials. Ipamorelin has the better clinical development history; GHRP-6 has more published receptor pharmacology.
Evidence Context Favoring GHRP-6
Research where appetite stimulation or broad hormonal activation is intentionally studied.
Evidence Context Favoring Ipamorelin
GH research requiring hormonal selectivity, or clinical contexts where cortisol and appetite perturbation are undesirable.
Side-by-Side Snapshot
| Evidence grade | GHRP-6: Level C Ipamorelin: Level B |
|---|---|
| Research status | GHRP-6: Preclinical Ipamorelin: Phase 2 |
| Primary category | GHRP-6: Growth Hormone Ipamorelin: Growth Hormone |
| Cited studies | GHRP-6: 2 Ipamorelin: 3 |